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EmbryotoxicityAbstract Verapamil is a calcium channel blocker that has been widely used in the treatment of car-
diovascular abnormalities, hypertension and angina pectoris. The present study investigates the
effect of bee venom against verapamil embryotoxicity, bee venom (BV) is characterized with anti-
cancer, anti-inflammatory, anti-rheumatoid, pain-relieving and neuroprotective agents. The current
study was carried out on 70 pregnant female mice which were divided into two main groups, the first
main group divided into three subgroups, control, treated with single and twice dose daily of ver-
apamil (40 mg/kg) that was treated from zero day of gestation to scarification of females at E10.
The second main group that was treated from the seventh day of gestation was divided into four
subgroups, control, treated with single dose daily of verapamil (40 mg/kg), injected with bee venom
(150 lg/kg/BW) and treated with verapamil combined with bee venom, the females were sacrificed
at E14 and E17. The results of this study showed that verapamil treated groups once or twice daily
in the first main experiment showed abortion and resorption of uteri embryos. In the second main
experiment, developing liver and kidney at E14 and E17 in verapamil treated group showed abnor-
mal architecture of histological picture and alterations of immunohistochemical expression of heat
shock protein and BAK that were associated with ultrastructure abnormalities at E17. Bee venom
treated group showed the similar structure as control, verapamil combined with bee venom treated
group exhibited amelioration against verapamil embryotoxicity. In conclusion, bee venom could be
considered as a therapeutic agent and it has a curative effect against the toxicity of verapamil during
development of liver and kidney.
 2016 The Egyptian German Society for Zoology. Production and Hosting by Elsevier B.V. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Calcium channel blockers (CCBs) or calcium antagonists are
among the most widely used drugs in cardiovascular medicineand regulation of blood pressure in hypertensive patients
(Girvin and Johnston, 2004; Lipsitz et al., 2005; Pavlovic
et al., 2004). Verapamil is an L-type voltage-dependent calcium
channel blocker, belongs to the phenylalkylamine group, and
has been used in the treatment of angina pectoris, cardiovascu-
lar abnormalities, hypertension, cardiac arrhythmia and coro-
nary vasospasm (Kumar and Hall, 2003; Grossman and
14 A.A. SeleemMesserli, 2004; Hirota et al., 2004; Wu et al., 2004). Verapamil
given either in vivo or in vitro has been shown to inhibit calcium
uptake (Goligorsky et al., 1985) and any alterations in calcium
homeostasis can be quite toxic (Choi, 1992) where the concen-
tration of cytosolic calcium is a key factor for control of many
diverse cellular and pathophysiological functions. Calcium
channel blockers have been shown in animal experiments to
be able to induce teratogenic effects and increase the incidence
of embryolethality (Fukunishi et al., 1980; Cabov and Palka,
1984; Robert et al., 2011). Verapamil, is a classic chemo-
sensitizer which can enhance the antitumor effect in several
cancer cells including neuroblastoma, lung and colorectal can-
cer (Ikeda et al., 1987; Wang et al., 2010; Koski et al., 2012).
Bee venom (BV) is the venom that bees store within their
venom sacs for self-defense which is also known as apitoxin, it
is extracted from honeybees and is commonly used in Oriental
medicine to relieve pain and treat inflammatory diseases. Bee
venom is known to be a very complex mixture of at least 18
active components including active peptides, melittin (a major
component of BV), apamin, adolapin (Kwon et al., 2005) and
amines that contain histamine, catecholamines, polyamines,
melittin, and phospholipase A2 (Orsˇolic´, 2012). Melittin is the
principal component of BV and constitutes approximately
50% of its dry weight (Vogel, 1981). Bee venom is introduced
natural anticancer agents (Orsˇolic´ et al., 2003; Gajski and
Garaj-Vrhovac, 2011), Anti-mutagenic, (Varanda et al.,
1999), anti-inflammatory (Nam et al., 2003), anti-nociceptive,
(Kim et al., 2003), anti-rheumatoid arthritis (Kwon et al.,
2005), pain-relieving (Kwon et al., 2001), neuroprotective
(Alvarez-Fischer et al., 2013) and immune modulatory activity
(Nam et al., 2005). The aim of the present study was to examine
the ameliorative effect of bee venom against embryotoxicity of
calcium channel blockers (verapamil) during development of
liver and kidney at prenatal stages E14 and E17.
Material and methods
Chemicals
Verapamil was obtained from Sigma–Aldrich Company USA.
Bee venom of Apis mellifera was obtained from Faculty of
Agriculture, Assuit University.
Animals and experimental design
Adult female and male miceMus musculus (weighting 25–30 g)
were used. The animals were obtained from a closed random
bred colony at Faculty of Science, Sohag University, Egypt.
The mice were maintained on food and water ad libitum and
housed in groups in isolated cages. The animals were acclima-
tized for 2 weeks prior to usage. A male and two females were
placed in one cage and left overnight. The presence of the vagi-
nal plug, next morning was considered as fertilization indica-
tor, and was considered zero day of pregnancy. Seventy
pregnant female were divided into two main groups, the first
main group (primary experiment) that was treated from zero
day of gestation to prenatal E10 was divided into three sub-
groups (10 each), control, treated with single dose daily and
twice dose daily in the morning and in the evening of vera-
pamil (40 mg/kg). The second main group (essential experi-
ment) was designed after the results of the primaryexperiment. The studied pregnant females of the second main
groups were treated from the 7th day of pregnancy to sacrifi-
cation at prenatal stages E14 and E17 that were divided into
four subgroups (10 each), control, treated with single dose
daily of verapamil (40 mg/kg), treated with bee venom subcu-
taneously injected (150 lg/kg/BW) (Alvarez-Fischer et al.,
2013) and treated with verapamil single dose combined with
bee venom subcutaneously injected.
Histological examination
The whole embryos at prenatal stages E14 and E17 of studied
groups were fixated in carnoy’s fixative, dehydrated in ethyl
alcohol, cleared in methyl benzoate, toluene and mounted in
paraffin wax. Serial section (7 l thick) of the selected tissues
from livers and kidneys were stained by hematoxylin and eosin
for general histology (Drury and Wallington, 1976).
Immunohistochemical investigation
Sections of selected liver and kidney at E14 and E17 of the sec-
ond main experiment were mounted on Superfrost/Plus glass
slides. The slides were deparaffinized in xylene, rehydrated in
serial alcohol and retrieved for re-antigenicity using 10 mM
citrate buffer at pH6 at 100 C in oven for an hour
(Buchlowalow and Bocker, 2010). Sections were incubated
with specific primary antibody against anti-HSP70 (rabbit
polyclonal, spring, Bioscience, USA) and BAK (rabbit poly-
clonal antibody, Santa Cruz, Biotechnology, INC., Germany),
for three hours at room temperature. Sections were then
washed using phosphate buffer and incubated with secondary
antibody (biotinylated goat anti-polyvalent HRP DAB detec-
tion system, Spring Bioscience, USA). Then sections were
washed with phosphate buffer and then visualized by mix
chromogen solution with DAB. Stained sections were mounted
with DPX mounting media and investigated under light micro-
scope (Axio Scope, Zeiss, Germany).
Transmission electron microscope study
Liver and kidney samples at E17 from the different subgroups
of the second main experiment were fixated in 2.5% glu-
taraldehyde (Mercer and Birbeck, 1972), then washed twice
in distilled water, then post-fixed in 1% osmium tetroxide, then
washed twice in distilled water and dehydrated in ascending
series of ethanol. At the stage of clearing, samples were passed
in propylene oxide. In the infiltration process samples were
transferred to a mixture of propylene oxide with epon resin
1:1. The samples were then embedded in pure epon resin in
blocks at 60 C overnight. Ultrathin sections were cut using
ultratome (Reichert, Supernova, Germany) and were mounted
in grids, stained with uranyl acetate and lead citrate (Reynold,
1963). Sections were examined and photographed under a Joel
Transmission Electron Microscopy (JEM 1010, Japan).
Results
Toxicological observation
The females of verapamil treated groups either once or twice
daily that were treated from zero day of gestation showed
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abortion at prenatal stage E10 as compared with the control
group. Also, the percentage of abortion and resorption of
embryos in the twice treated groups (arrows, Plate 1C) was
higher than the once treated ones (arrows, Plate 1B) as com-
pared with the control group (Plate 1A). Verapamil treated
group that were treated from the seventh day of gestation in
the second main experiment showed resorbed embryos (arrow,
Plate 1E) at E14, bee venom treated group didn’t elucidate any
resorbed embryos (Plate 1F), verapamil combined with bee
venom group showed recovery of resorption effect of vera-
pamil (Plate 1G) as compared to the control group (Plate 1D).
Histological, immunohistochemical and ultrastructural
investigation of liver
Hematoxylin and eosin staining of developing liver at E14
showed that the control group had a normal architecture of
hematopoietic cells (Plate 2A). Verapamil treated group at
E14 showed loose arrangement of hematopoietic cells thatPlate 1 Photographs of uterus in the different groups of primary exp
treated with single (arrows, B) and twice (arrows, C) dose showed resor
E14 of different groups, control (D), verapamil treated group show
combined with bee venom (G) treated groups showed similar picturewere separated from each other with numerous nucleated red
blood cells (arrow, Plate 2B). Bee venom treated group (Pla-
te 2C) showed similarity with control structure. Verapamil
combined with bee venom group didn’t exhibit verapamil dis-
turbances (Plate 2D). The developing liver of control group at
E17 consists of primitive hepatic cords of hepatocytes and pri-
mary blood sinusoids (Plate 2E). Verapamil treated group
(Plate 2F) showed loosely arranged hepatocytes, hemorrhage
(white arrows), aggregation of inflammatory cells (red arrow)
and the majority of the apoptotic cells were identified as hep-
atocytes based on their larger size with large eosinophilic cyto-
plasm (black arrow). Bee venom treated group elucidated the
same architectural pattern of control (Plate 2G), verapamil
combined with bee venom treated group showed improvement
of the dangerous effects of verapamil (Plate 2H).
Immunohistochemistry staining of heat shock protein
(HSP) expression in control group of developing liver at E14
(Plate 3A) and E17 (Plate 3E) showed faint staining. Vera-
pamil treated group at E14 (arrow, Plate 3B) and E17 (arrow,
Plate 3F) showed an increase in the expression of HSP. Beeeriment at prenatal stage E10, control (A), verapamil groups daily
bed embryos. Uterus of the secondary experiment at prenatal stage
ed resorbed embryo (arrow, E), bee venom (F) and verapamil
to control.
Plate 2 Photomicrographs of H&E staining of developing liver at E14 showed the normal structure of hematopoietic (H) cells and blood
vessel (BV) in control group (A), verapamil treated group exhibited loosely arranged hematopoietic cells (arrows, B). Bee venom (C) and
verapamil combined with bee venom treated (D) groups didn’t exhibit verapamil disturbances. Developing liver of control group at E17
(E) showed hepatic strands (HS) and blood vessel (BV), verapamil treated group (F) elucidated loosely arranged hepatocytes, hemorrhage
(white arrows), eosinophilic cytoplasm (black arrow) and aggregation of inflammatory cells (red arrow). Bee venom (G) and verapamil
combined with bee venom (H) treated groups showed improvement of the dangerous effects of verapamil. Scale bar 10 lm.
16 A.A. Seleemvenom treated group didn’t reveal any increase in expression at
E14 (Plate 3C) and E17 (Plate 3G). Verapamil combined with
bee venom treated group elucidate amelioration in the expres-
sion of HSP at E14 (Plate 3D) and E17 (Plate 3H) as compared
with verapamil treated group. Immunohistochemistry staining
of BAK showed a reduction in the expression in the verapamiltreated group at E14 (arrows, Plate 4B) and E17 (arrows, Pla-
te 4F) as compared with the normal expression in the control
group at E14 (Plate 4A) and E17 (Plate 4E). Bee venom treated
group exhibited similarity in BAK expression with control
group at E14 (Plate 4C) and E17 (Plate 4G). Verapamil com-
bined with bee venom treated group elucidated recovery of
Plate 3 Photomicrographs of heat shock protein immunostained of developing liver in control group at E14 (A) and E17 (E) showed
faint staining. Highly marked increase was detected in the verapamil treated group at E14 (arrow, B) and E17 (arrow, F). Bee venom
treated at E14 (C), E17 (G) and verapamil combined with bee venom group at E14 (D) and E17 (H) didn’t reveal any increase in heat
shock protein expression. Scale bar 10 lm.
Protective effect of bee venom against verapamil embryotoxicity 17expression and became similar to control at E14 (Plate 4D)
and E17 (Plate 4H).
Ultrastructure of hepatocytes in developing liver of control
group at E17 (Plate 8A) was characterized by the normal
architecture of nucleus, mitochondria, endoplasmic reticulum,
nuclear membrane and normal chromatin on the nuclear mem-
brane. Hepatocytes of verapamil treated group at E17 showedseveral morphological distortions as severe decline of endo-
plasmic reticulum, fragmented and decomposed mitochondria,
shrunken nuclei (pyknosis), irregular nuclear membrane,
abnormal chromatin condensation on the nuclear membrane,
small amounts of lipid droplets and vacuoles (V) of varying
sizes (arrows, Plate 8B). Bee venom treated group didn’t show
any change in ultrastructure of hepatocytes at E17 (Plate 8C).
Plate 4 Photomicrographs of BAK immunostained of developing liver in control group at E14 (A) and E17 (E) showed normal
expression. Verapamil treated group at E14 (arrows, B) and E17 (arrows, F) showed reduction of BAK expression. Bee venom treated at
E14 (C), E17 (G) and verapamil combined with bee venom at E14 (D) and E17 (H) groups exhibited similarity in expression with control
group. Scale bar 10 lm.
18 A.A. SeleemVerapamil combined with bee venom treated group (Plate 8D)
exhibited amelioration in the abnormalities of verapamil
effects.
The normal distribution of carbohydrates content in PAS
staining was observed in the developing liver of control group
at E17 (Plate 9A), verapamil treated group (Plate 9B) showed amarked decrease in the carbohydrate content. Bee venom trea-
ted group (Plate 9C) showed a similar distribution of carbohy-
drates to the control group. Verapamil combined with bee
venom treated group (Plate 9D) exhibited recovery abnormal-
ities of carbohydrate distribution that was induced by
verapamil.
Plate 5 Photomicrographs of H&E stained in developing control kidney at E14 (A) and E17 (E) showed normal structure of glomerulus
(G) and renal tubules (T). Verapamil treated group at E14 (B) and E17 (F) exhibited atrophy, shrinkage of renal corpuscle and
disorganization of kidney tubules. Developing kidney in bee venom treated group at E14(C), E17 (G) and combined group of verapamil
with bee venom at E14 (D) and E17 (H) showed similar structure of control. Scale bar 10 lm.
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examination of kidney
The histological picture of kidney in control group at E14 (Pla-
te 5A) and E17 (Plate 5E) showed renal parenchyma, develop-
ing of glomerulus and kidney tubules. Verapamil treated group
at E14 (Plate 5B) and E17 (Plate 5F) showed atrophy and
shrinkage of renal corpuscle, decrease in glomerular cellularity,disorganization and degeneration of kidney tubules. Bee
venom treated group showed a similar structure to control
either at E14 (Plate 5C) or E17 (Plate 5G). The combined
group of verapamil with bee venom at E14 (Plate 5D) and
E17 (Plate 5H) elucidated amelioration in the kidney
parenchymatous organizations, glomerulus and tubules as
compared with verapamil effects.
Developing kidney of the control group at E14 (Plate 6A)
showed faint expression of heat shock protein (HSP) in the
Plate 6 Photomicrographs of heat shock protein immunostained of developing kidney in control group at E14 (A) and E17 (E). Highly
marked increase in heat shock protein was detected in the verapamil treated group at E14 (arrows, B) and E17 (arrows, F). Bee venom
treated group at E14 (C), E17 (G) and verapamil combined with bee venom treated group at E14 (D) and E17 (H) didn’t show any
disturbance in heat shock protein expression. Scale bar 10 lm.
20 A.A. Seleemtubules and mesenchyme tissue that was increased at E17 (Pla-
te 6E). Elevation of HSP expression was detected in the devel-
oping kidney tubules and mesenchyme tissue of the verapamil
treated group at E14 (Plate 6B) and E17 (Plate 6F). Bee venom
treated group didn’t reveal any change in HSP expression at
E14 (Plate 6C) and E17 (Plate 6G). Verapamil combined with
bee venom treated group elucidate amelioration in HSPexpression at E14 (Plate 6D) and E17 (Plate 6H). Developing
kidney of control group at E14 (Plate 7A) showed normal
BAK expression that that was increased at E17 (Plate 7E).
Verapamil treated group showed a decrease in BAK expression
at E14 (Pl7B) and E17 (Plate 7F). Bee venom treated group
exhibited similarity in BAK expression with control group at
E14 (Plate 7C) and E17 (Plate 7G). Verapamil combined with
Plate 7 Photomicrographs of BAK immunostained of developing kidney in control group at E14 (A) and E17 (E). Verapamil treated
group at E14 (arrows, B) and E17 (arrows, F) showed reduction of BAK expression. Bee venom treated group exhibited similarity in
expression with control group at E14 (C) and E17 (G). Verapamil combined with bee venom group treated group elucidated recovery of
expression and return to control at E14 (D) and E17 (H). Scale bar 10 lm.
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sion and became similar to control at E14 (Plate 7D) and
E17 (Plate 7H).
The ultrastructure of developing kidney tubules of control
group at E17 showed normal appearance of proximal convo-
luted tubule (PCT) (Plate 8E) and distal convoluted tubules
(DCT) (Plate 8I). PCT is lined by simple cuboidal epitheliumthat have long microvilli (Mv) forming the brush border.
PCT and DCT have large rounded nuclei (N) with normal
peripheral chromatin distribution, well defined nucleolus
(NC), mitochondria (M) and normal thickness of basement
membrane (BM). In verapamil treated group, destruction
and reduction in the number and size of apical microvilli of
PCT (arrows, Plate 8F) were noted. Intracellular vacuolations
Plate 8 Transmission electron micrograph of transverse section of hepatocytes in control group at E17 (A) is characterized by the
normal architecture of nucleus (N), nucleolus (NC), heterochromatin (HC), Euchromatin (EC), nuclear membrane (NM), mitochondria
(M) and endoplasmic reticulum (ER). Verapamil treated group suffers from decline in the endoplasmic reticulum, fragmented
mitochondria, shrunken nuclei, irregular nuclear membrane, abnormal chromatin condensation, large vacuoles (V) and small (arrows, B).
Bee venom treated group didn’t show any change in ultrastructure of hepatocytes (C). Verapamil combined with bee venom group
exhibited amelioration in the abnormalities of verapamil (D). Developing kidney tubules in control group at E17 contains proximal
convoluted tubule (PCT) (E) and distal convoluted tubule (DCT) (I) with large rounded nuclei (N), nucleolus (NC), mitochondria (M) and
basement membrane (BM). Verapamil treated group in PCT (F) and DCT (J) showed destruction of apical microvilli (arrows) in PCT and
suffers from vacuoles (V), lysosomes (L), fragmented mitochondria (M), basement membrane thickening (BM), shrinking nucleus (N) with
irregular shape and abnormal distribution of peripheral chromatin. Bee venom treated group didn’t show any alteration in ultrastructure
of PCT (G) and DCT (K). Verapamil combined with bee venom group exhibited amelioration in the ultrastructure of PCT (H) and DCT
(L). Magn. A-D 6000, E-L 4000.
22 A.A. Seleem
Plate 9 Photomicrographs of PAS staining of developing control liver (A) and kidney (E) at E17 showed normal distribution of
carbohydrates content that was marked decrease in verapamil treated group in liver (B) and kidney (F). Bee venom treated group showed
normal distribution of PAS staining in liver (C) and kidney (G). Verapamil combined with bee venom treated group exhibited recovery in
the abnormalities of carbohydrates distribution in the liver (D) and kidney (H). Scale bar 10 lm.
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mitochondria (M), thickening of basement membrane (BM),
shrinking nucleus (N) with irregular shape and clumps with
abnormal distribution of peripheral chromatin were noted in
PCT (Plate 8F) and DCT (Plate 8J). Bee venom treated group
at E17 didn’t show any alteration in ultrastructure of proximal
convoluted tubules (Plate 8G) and distal convoluted tubules(Plate 8K). Verapamil combined with bee venom group exhib-
ited amelioration in the ultrastructure of proximal convoluted
tubules (Plate 8H) and distal convoluted tubules (Plate 8L).
The normal appearance of PAS staining in kidney of con-
trol group at E17 (Plate 9E) was observed in the basement
membrane of Bowman capsule and the brush border of prox-
imal convoluted tubules. Verapamil treated group at E17
24 A.A. Seleemexhibited reduction in PAS staining of the basement mem-
brane of Bowman capsule and altered brush border of PCT
(Plate 9F). Bee venom treated group at E17 showed the similar
distribution of PAS staining (Plate 9G) as the control group.
Verapamil combined with bee venom treated group exhibited
recovery (Plate 9H) in the abnormalities of carbohydrate dis-
tribution that was induced by verapamil.Discussion
The present study demonstrated the dangerous effects of vera-
pamil that cause abortion and resorption of embryos either in
daily or twice treatment of verapamil (40 mg/kg) in the pri-
mary experiment and cause histological and ultrastructure
alterations during the development of liver and kidney at
E14 and E17 in the secondary experiment. Previous studies
have shown that verapamil at dose (60 mg/kg/day) may cause
miscarriages via inhibiting implantation (Uslu et al., 2013). In
addition, previous use of verapamil in the treatment of fetal
paroxysmal tachycardia (Wolff et al., 1980; Lilja et al., 1984;
Truccone and Mariona, 1985) and during tocolytic therapy
(Strigl et al., 1981) coincided with the results of this study.
By the same token, verapamil causes neural tube closure
defects (Lee and Nagele, 1986), growth retardation, abnormal-
ities in forelimbs, heart, head and yolk sac circulation (Stein
et al., 1990). In addition, calcium channel blockers induce ter-
atogenic effects of embryos (Fukunishi et al., 1980; Cabov and
Palka, 1984; Robert et al., 2011).
Calcium plays a crucial role in regulation of cellular pro-
cesses (Rasmussen, 1986). Endoplasmic reticulum of the liver
is the major intracellular calcium pool (Somilyo et al., 1985)
and intracellular calcium homeostasis is maintained by cooper-
ation between cellular transport and the individual compart-
ments of the cell (Claret-Berthon et al., 1977; Carafoli,
1987). An impairment of the calcium-regulating systems is
often associated with an uncontrolled increase in the cytosolic
calcium concentration (Lauterburg, 1987; Thurman et al.,
1988; Okuda et al., 1992). Verapamil, a calcium channel
blocker has been shown to inhibit calcium uptake
(Goligorsky et al., 1985) where it act as ligands, binding
strongly to the cellular membranes and thereby inhibiting cal-
cium influx (Bogin et al., 1981). Thus, verapamil is commonly
used as a calcium channel blocker for management of ischemic
heart diseases, supraventricular tachyarrhythmias, active
antianginal, antiarrhythmic, mitral stenosis, migraine prophy-
laxis and antihypertensive (McCall, 1976; Johnston et al.,
1981; Opie, 2005; Dong-Yun et al., 2010). In addition, some
studies have investigated the protective effect of verapamil
on the inflammatory response in the liver during endotoxic
(Standiford et al., 1995; Cavaillon et al., 1992). neuroprotec-
tive in several acute neurotoxicity models (Liu et al., 2011)
antiproliferative effect on tumor cell in vivo and in vitro
(Schmidt et al., 1988 and Jian et al., 2007) and nephroprotec-
tive effect against lead, cadmium, mercuric chloride, cephalos-
porins, gentamycin toxicity (Watson et al., 1987; Sleijfer et al.,
1987; Ali et al., 2002; Zhang et al., 2013).
Bee venom treated group showed the similar histological
and ultrastructure picture to control. Also, it showed protec-
tion properties against verapamil embryotoxicity at E14 and
E17 during development of liver and kidney. Many studies
on the biological and pharmacological activities of BV havebeen carried out. BV is a well-established hepatoprotective
agent and has the ability to circumvent the hepatocellular
toxicity induced by methotrexate (Darwish et al., 2013). Also,
the radioprotective, antimutagenic, anti-inflammatory, antiar-
thritic, antihyperalgesic and antinociceptive effects of BV have
been documented (Park et al., 2004; Roh et al., 2004; Son
et al., 2007; Elshater et al., 2014). In addition, BV has protec-
tive effects on renal tubular injury (Clark et al., 1999;
Hyunseong et al., 2013; Elshater et al., 2014). BV has been pro-
ven to be a useful compound in potentiating the apoptotic kill-
ing capacity of some chemotherapeutic agents such as
bleomycin in cancer cell lines (Orsˇolic´, 2009; Jo et al., 2012).
Several studies have demonstrated that BV and/or melittin
have direct antitumor effects in vivo (Liu et al., 2002;
Orsˇolic´, 2012; Russell et al., 2004) and in vitro on various types
of cancerous cells, including liver (Liu et al., 2008), bone (Chu
et al., 2007), prostate, breast, cervical, and renal cancer cells
(Park et al., 2010, 2011).
Apamin is important component of bee venom (BV) and it
has a potent to increases of intracellular calcium during an
action potential (Bond et al., 2004). Apamin is possibly a cru-
cial component in bee venom regarding its protective action
that is due to a moderate and persistent elevation of cytosolic
calcium (Salthun-Lassalle et al., 2004). Another molecule in
bee venom might enhance the action of apamin called Melittin
that has several interesting pharmacological properties as a
result of its interaction with negatively changed phospholipids.
Also, it inhibits the activity of the Na/K-ATPase (Yang and
Carrasquer, 1997; Lopina, 2001). Furthermore, the specific
character of the major BV component melittin has an anti-
calmodulin activity through which it forms a calcium-
dependent high-affinity complex of calmodulin and melittin
(Tanaka et al., 1985). Other studies cited several mechanisms
of BV cytotoxicity, including cell cycle alterations, effects on
proliferation and/or growth inhibition and induction of apop-
tosis or necrosis (Gajski and Garaj-Vrhovac, 2013).
Verapamil treated group showed elevation in the expression
of heat shock proteins (HSPs) during development of liver and
kidney at E14 and E17 that may be attributed to HSPs that
have been associated with cytoprotection during stress and
may help to restore cellular integrity and promote recovery
in renal tubular cells exposed to ischemic injury (Aufricht
et al., 1998; Emami et al., 1991; Van Why and Siegel, 1998).
By the same token, Vicencio et al., 2003 demonstrated an
increased activation of HSP in immature rat tubules exposed
to anoxia compared with mature tubules (Gaudio et al.,
1998). Moreover, one feature of the protection mechanism of
HSP involves altered calcium ion homeostasis (Smith et al.,
1995). On the contrary, verapamil treated group showed inhi-
bition of BAK expression during liver and kidney development
at E14 and E17 as compared to control. BAK is a member of
BCL-2 family, reduction of BCL-2 expression increases cell
death to perform the tissue morphogenesis during develop-
ment or the organ functions (Maskey et al., 2009). At the same
context, BCL-2 family proteins are inhibitors and inducers of
cell death (Hardwick and Soane, 2013). In addition, BCL-2
was found to promote cell survival as opposed to promoting
cell proliferation (Vaux et al., 1988; Tsujimoto, 1989). More-
over, BAK controls apoptosis through the regulation of cal-
cium levels (Klee and Pimentel-Muinos, 2005). In conclusion,
the present investigation revealed the adverse effects of a cal-
cium channel blocker, verapamil that are represented in the
Protective effect of bee venom against verapamil embryotoxicity 25alteration of the histological picture of the developing liver and
kidney, overexpression of heat shock proteins and reduction of
BAK expression. Also, the study demonstrated the curative
effect of bee venom against verapamil embryotoxicity.Acknowledgement
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